iSpecimen Stock (NASDAQ:ISPC)
Previous Close
$5.20
52W Range
$3.41 - $14.60
50D Avg
$5.26
200D Avg
$6.81
Market Cap
$3.18M
Avg Vol (3M)
$159.66K
Beta
1.59
Div Yield
-
ISPC Company Profile
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
ISPC Performance
Peer Comparison
Ticker | Company |
---|---|
GTH | Genetron Holdings Limited |
HTGM | HTG Molecular Diagnostics, Inc. |
PSNL | Personalis, Inc. |
BIOC | Biocept, Inc. |
OCX | OncoCyte Corporation |
XGN | Exagen Inc. |
SQL | SeqLL Inc. |
CSTL | Castle Biosciences, Inc. |
TTOO | T2 Biosystems, Inc. |
OLK | Olink Holding AB (publ) |
FONR | FONAR Corporation |
INBS | Intelligent Bio Solutions Inc. |
TRIB | Trinity Biotech plc |